Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-03-03 Purchase |
2022-03-18 5:14 pm |
Silverback Therapeutics Inc. | SBTX | ROOT JONATHAN D Director |
2,364 | $15.25 | $36,048 | 2,271,781 (Indirect Direct) |
View |
| 2020-12-08 Purchase(A) |
2022-02-24 7:55 pm |
Silverback Therapeutics Inc. | SBTX | Hawkinson Russ Sr. Vice President of Finance |
200 | $21 | $4,200 | 200 (Direct) |
View |
| 2020-12-08 Purchase |
2020-12-08 9:04 pm |
Silverback Therapeutics Inc. | SBTX | Presidio Management Group XII L.L.C. U.S. Venture Partners XII L.P. U.S. Venture Partners XII-A L.P. Tansey Casey M 10% Owner |
47,619 | $21 | $999,999 | 47,619 (Indirect) |
View |
| 2020-12-08 Purchase |
2020-12-08 8:56 pm |
Silverback Therapeutics Inc. | SBTX | CAPPS VICKIE L Director |
9,523 | $21 | $199,983 | 61,576 (Direct) |
View |
| 2020-12-08 Purchase |
2020-12-08 8:52 pm |
Silverback Therapeutics Inc. | SBTX | Hawkinson Russ Sr. Vice President of Finance |
238 | $21 | $4,998 | 238 (Direct) |
View |
| 2020-12-08 Purchase |
2020-12-08 8:50 pm |
Silverback Therapeutics Inc. | SBTX | Piazza Jonathan Chief Financial Officer |
11,904 | $21 | $249,984 | 11,904 (Direct) |
View |
| 2020-12-08 Purchase |
2020-12-08 8:48 pm |
Silverback Therapeutics Inc. | SBTX | Schroeder Thilo Director |
238,096 | $21 | $5,000,016 | 1,910,029 (Indirect) |
View |
| 2020-12-08 Purchase |
2020-12-08 8:46 pm |
Silverback Therapeutics Inc. | SBTX | ROOT JONATHAN D Director |
95,238 | $21 | $1,999,998 | 200,250 (Indirect Direct) |
View |
| 2020-12-08 Purchase |
2020-12-08 8:43 pm |
Silverback Therapeutics Inc. | SBTX | Thompson Peter A. Director 10% Owner |
1,190,477 | $21 | $25,000,017 | 1,221,700 (Indirect) |
View |
| 2020-12-08 Purchase |
2020-12-08 8:41 pm |
Silverback Therapeutics Inc. | SBTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC ORBIMED CAPITAL LLC Director 10% Owner |
1,190,477 | $21 | $25,000,017 | 1,221,700 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-06-10 Option Award |
2022-06-13 7:48 pm |
N/A 2032-06-09 |
Silverback Therapeutics Inc. | SBTX | ROOT JONATHAN D Director |
18,000 | $0 | 18,000 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-13 7:44 pm |
N/A 2032-06-09 |
Silverback Therapeutics Inc. | SBTX | Powell Andrew Kenneth William Director |
18,000 | $0 | 18,000 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-13 7:39 pm |
N/A 2032-06-09 |
Silverback Therapeutics Inc. | SBTX | Koehler Maria Director |
18,000 | $0 | 18,000 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-13 7:33 pm |
N/A 2032-06-09 |
Silverback Therapeutics Inc. | SBTX | Islam Saqib Director |
18,000 | $0 | 18,000 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-13 7:31 pm |
N/A 2032-06-09 |
Silverback Therapeutics Inc. | SBTX | HERSHBERG ROBERT Director |
18,000 | $0 | 18,000 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-13 7:27 pm |
N/A 2032-06-09 |
Silverback Therapeutics Inc. | SBTX | CAPPS VICKIE L Director |
18,000 | $0 | 18,000 (Direct) |
View |
| 2022-05-02 Option Award |
2022-05-04 5:19 pm |
N/A 2032-05-01 |
Silverback Therapeutics Inc. | SBTX | Shawver Laura Chief Executive Officer |
204,321 | $0 | 311,716 (Direct) |
View |
| 2022-05-02 Option Award |
2022-05-04 5:16 pm |
N/A 2032-05-01 |
Silverback Therapeutics Inc. | SBTX | Piazza Jonathan Chief Financial Officer |
131,074 | $0 | 156,608 (Direct) |
View |
| 2022-05-02 Option Award |
2022-05-04 5:12 pm |
N/A 2032-05-01 |
Silverback Therapeutics Inc. | SBTX | Odegard Valerie President and CSO |
135,700 | $0 | 152,106 (Direct) |
View |
| 2022-05-02 Option Award |
2022-05-04 5:07 pm |
N/A 2032-05-01 |
Silverback Therapeutics Inc. | SBTX | Hunder Naomi Chief Medical Officer |
129,532 | $0 | 140,782 (Direct) |
View |
| 2022-05-02 Option Award |
2022-05-04 5:00 pm |
N/A 2032-05-01 |
Silverback Therapeutics Inc. | SBTX | Hawkinson Russ Sr. Vice President of Finance |
85,005 | $0 | 93,921 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-02 5:22 pm |
N/A 2032-01-31 |
Silverback Therapeutics Inc. | SBTX | Hawkinson Russ Sr. Vice President of Finance |
81,000 | $0 | 82,454 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-02 5:19 pm |
N/A 2032-01-31 |
Silverback Therapeutics Inc. | SBTX | Piazza Jonathan Chief Financial Officer |
121,500 | $0 | 135,784 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-02 5:18 pm |
N/A 2032-01-31 |
Silverback Therapeutics Inc. | SBTX | Hunder Naomi Chief Medical Officer |
121,500 | $0 | 121,500 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-02 5:17 pm |
N/A 2032-01-31 |
Silverback Therapeutics Inc. | SBTX | Shawver Laura Chief Executive Officer |
297,000 | $0 | 376,895 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-02 5:16 pm |
N/A 2032-01-31 |
Silverback Therapeutics Inc. | SBTX | Odegard Valerie President and CSO |
164,719 | $0 | 164,719 (Direct) |
View |
| 2021-12-13 Other |
2021-12-15 2:56 pm |
N/A N/A |
Silverback Therapeutics Inc. | SBTX | ROOT JONATHAN D Director |
2,174,179 | $0 | 2,269,417 (Indirect) |
View |
| 2021-06-04 Option Award |
2021-09-21 5:14 pm |
N/A 2031-06-03 |
Silverback Therapeutics Inc. | SBTX | Thompson Peter A. Director 10% Owner |
15,000 | $0 | 15,000 (Direct) |
View |
| 2021-06-04 Option Award |
2021-09-21 5:10 pm |
N/A 2031-06-03 |
Silverback Therapeutics Inc. | SBTX | ROOT JONATHAN D Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2021-06-04 Option Award |
2021-09-21 5:08 pm |
N/A 2031-06-03 |
Silverback Therapeutics Inc. | SBTX | Powell Andrew Kenneth William Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2021-06-04 Option Award |
2021-09-21 5:06 pm |
N/A 2031-06-03 |
Silverback Therapeutics Inc. | SBTX | Islam Saqib Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2021-06-04 Option Award |
2021-09-21 5:04 pm |
N/A 2031-06-03 |
Silverback Therapeutics Inc. | SBTX | HERSHBERG ROBERT Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2021-06-04 Option Award |
2021-09-21 5:03 pm |
N/A 2031-06-03 |
Silverback Therapeutics Inc. | SBTX | CAPPS VICKIE L Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2021-03-12 Option Award |
2021-03-16 3:09 pm |
N/A 2031-03-11 |
Silverback Therapeutics Inc. | SBTX | Koehler Maria Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2020-12-08 Conversion |
2020-12-08 9:04 pm |
N/A N/A |
Silverback Therapeutics Inc. | SBTX | Presidio Management Group XII L.L.C. U.S. Venture Partners XII L.P. U.S. Venture Partners XII-A L.P. Tansey Casey M 10% Owner |
10,246,912 | $0 | 47,619 (Indirect) |
View |
| 2020-12-08 Conversion |
2020-12-08 8:48 pm |
N/A N/A |
Silverback Therapeutics Inc. | SBTX | Schroeder Thilo Director |
7,879,822 | $0 | 1,910,029 (Indirect) |
View |
| 2020-12-08 Conversion |
2020-12-08 8:46 pm |
N/A N/A |
Silverback Therapeutics Inc. | SBTX | ROOT JONATHAN D Director |
10,246,912 | $0 | 200,250 (Indirect) |
View |
| 2020-12-08 Conversion |
2020-12-08 8:43 pm |
N/A N/A |
Silverback Therapeutics Inc. | SBTX | Thompson Peter A. Director 10% Owner |
33,046,445 | $0 | 1,221,700 (Indirect) |
View |
| 2020-12-08 Conversion |
2020-12-08 8:41 pm |
N/A N/A |
Silverback Therapeutics Inc. | SBTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC ORBIMED CAPITAL LLC Director 10% Owner |
33,046,445 | $0 | 1,221,700 (Indirect) |
View |
| 2020-12-08 Conversion |
2020-12-08 4:36 pm |
N/A N/A |
Silverback Therapeutics Inc. | SBTX | Alexandria Venture Investments LLC 10% Owner |
3,296,329 | $0 | 699,412 (Direct) |
View |
| 2020-12-03 Option Award |
2020-12-07 8:02 pm |
N/A 2030-12-02 |
Silverback Therapeutics Inc. | SBTX | Thompson Peter A. Director 10% Owner |
38,270 | $0 | 38,270 (Direct) |
View |
| 2020-12-03 Option Award |
2020-12-07 8:01 pm |
N/A 2030-12-02 |
Silverback Therapeutics Inc. | SBTX | Odegard Valerie President and CSO |
364,904 | $0 | 364,904 (Direct) |
View |
| 2020-12-03 Option Award |
2020-12-07 7:59 pm |
N/A 2030-12-02 |
Silverback Therapeutics Inc. | SBTX | Shawver Laura Chief Executive Officer |
562,631 | $0 | 562,631 (Direct) |
View |
| 2020-12-03 Option Award |
2020-12-07 7:58 pm |
N/A 2030-12-02 |
Silverback Therapeutics Inc. | SBTX | ROOT JONATHAN D Director 10% Owner |
38,270 | $0 | 38,270 (Direct) |
View |